Bexarotene in Treating Patients With Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama Comprehensive Cancer Center
Birmingham, Alabama, United States
- Arizona Cancer Center
Tucson, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Beckman Research Institute, City of Hope
Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
- Kaiser Permanente-Southern California Permanente Medical Group
San Diego, California, United States
- Ucsf Cancer Center and Cancer Research Institute
San Francisco, California, United States
- Yale Comprehensive Cancer Center
New Haven, Connecticut, United States
- Vincent T. Lombardi Cancer Research Center, Georgetown University
Washington D.C., District of Columbia, United States
- Baptist Regional Cancer Institute - Jacksonville
Jacksonville, Florida, United States
- Mayo Clinic Jacksonville
Jacksonville, Florida, United States
- Sylvester Cancer Center, University of Miami
Miami, Florida, United States
- Cancer Research Center of Hawaii
Honolulu, Hawaii, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Louisiana State University School of Medicine
New Orleans, Louisiana, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Michigan State University
East Lansing, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, United States
- Hematology Oncology Consultants Inc
Columbus, Ohio, United States
- Oregon Cancer Center at Oregon Health Sciences University
Portland, Oregon, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Sarah Cannon-Minnie Pearl Cancer Center
Nashville, Tennessee, United States
- University of Texas - Md Anderson Cancer Center
Houston, Texas, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
- Cancer Center, University of Virginia Hsc
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 1998
- Primary completion
- —
- Completion
- 31 Mar 2003
- Last update posted
- 30 May 2013
- Registered enrollment
- 180
- Registry id
- NCT00003752
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.